The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,648.50
Bid: 1,648.50
Ask: 1,649.00
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,642.00
High: 1,656.00
Low: 1,635.00
Prev. Close: 1,636.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday preview: BP, Barclays, Glaxo ...

Tue, 26th Apr 2011 16:12

It is just over a year since the Gulf of Mexico Macondo oil well tragedy, an event that will continue to loom large over oil colossus BP when it announces its first quarter results on what is a busy Wednesday for company results.However, recent events in Russia are likely to be more to the forefront of investors' minds, as well as the progress of the group's $30bn divestment programme.With all that going on it is easy to forget that the company's basic business is extracting oil and gas from the earth. Analyst Tony Shepard at broker Charles Stanley thinks first quarter production volumes could be down some 7% on a year earlier, "and as a result, BP will have less leverage from higher oil prices which are some 32% higher than a year ago.""Exploration & Production (E&P) profit may be similar to last year's level of $8.1bn," Shepard continued. "We expect a stronger performance from the downstream operations on the back of better indicated refining margins and efficiencies which could drive a profit of $1.5bn compared to $0.8bn a year ago. The quarterly dividend was reinstated in Q4 [fourth quarter] at a level of 7 cents per share and we expect this to be maintained through the year."For the group as a whole, Charles Stanley is predicting first quarter adjusted net income of $5.7bn, up from $5.6bn a year earlier.Last year could justifiably be described as an annus horribilis for BP in which it suffered its fair share of public outrage. Banking giant Barclays has borne the brunt of public outrage itself, and its interim management statement covering the first quarter is sure to garner some acidic press coverage outside of the City pages. Nomura Securities thinks the figures are likely to be down on last year, which may temper the press's ire, with the period unlikely to have been a vintage quarter for BarCap, the bank's investment banking arm."We assume BarCap profits of £1.2bn, down from £ 1.6bn the previous year. This includes a top-line income of £3.3bn, 13% lower than in Q1 last year. It also compares with £3.4bn in Q4, which benefited from non-recurring gains, we estimated to have been c. £300m, if apportioned according to risk assets," the Japanese broker said."We have assumed a continuation of the recovery in traditional banking profitability, but at a slower pace than last year. We assume Barclays Global Retail Bank contributes profit before tax of £537m, against £303m in Q1 last year. We also assume UK & Ireland profits of £243m up from £158m last year. However, across other commercial banking markets and especially in Spain, we expect losses to continue," the broker added.Out the same day are trading statements from chip designers ARM Holdings and Wolfson Microelectronics.Matrix group is bearish on ARM after its strong run over the last year, and thinks the market is overestimating the Cambridge firm's growth opportunities."We see revenues of £108.2m, adjusted operating profit of £44.9m (41.5% margin) and earnings per share (EPS) of 2.48p. Our estimates are broadly in line with consensus expectations (2.53p). We see clean OPEX [operational expenditure] of £57.2m, slightly lower than consensus," Matrix said.As for any fall-out from the Japanese earthquake, Matrix notes that: "ARM royalty revenues are recognised one quarter in arrears; any disruption in semiconductor shipments in Q2 2011 linked to recent events in Japan would not appear before Q3 2011. We do not think that licensing revenues, which historically have been quite lumpy, will suffer."The same broker is more upbeat about ARM's Scottish rival Wolfson Microelectronics, which it thinks is on the right track. "With 2009 and 2010 design wins ramping up to full production in 2011, we feel that the pipeline is very strong, in both smartphones and other applications such as TVs, tablets and game consoles. The only risk we see comes from the impact of the Japanese earthquake: any supply chain disruption will of course affect Wolfson's revenue and guidance.Matrix is forecasting first quarter revenues of $41.2m, slightly above the market consensus of $41.0m. It is below consensus on underlying operating profit, however, going for $0.2m, half the level the market is expecting. Underlying EPS is tipped to be 98 cents.One of the key issues in the trading statement could be the company's exposure to problems in Japan caused by March's earthquake and subsequent tsunami."There is still little clarity on how deeply the Japanese disaster will affect Wolfson. While the company's direct exposure to Japan is expected at 10-15% in 2011, not all customers' production facilities were affected, so the real impact will likely be smaller. The indirect effect, through wireless components shortages, is harder to assess and depends, among others things, on current inventory levels," Matrix believes. Primark and British Sugar owner Associated British Foods is another Footsie heavyweight that will be clamouring for attention on 27 April, and could see a continuation of the transfer in emphasis away from Primark to British Sugar as the main driver of growth in the short term."The depressed consumer environment in the UK has taken its toll on Primark's sales growth, with like for likes slipping to 2% in recent months, while margins remain under pressure from the rising cotton price. Sugar, by contrast, is doing better than expected despite the impact of the poor UK beet crop, with Spain and China performing strongly thanks to the tightness of global supply. Grocery has been held back by a disappointing Australian performance," broker RBS Hoare Govett said.The broker is not expecting Wednesday's trading statement to prompt a change in full year forecasts. It thinks management may focus attention on the potential profits windfall in 2012 from the sharp increase in European Union sugar prices in the event that it has better volumes from a normal beet crop. "This may push consensus EPS forecasts higher, though the continued pressure on Primark margins from high cotton prices remains a concern," RBS Hoare Govett concluded.Charles Stanley, meanwhile, thinks AB Foods will announce interim sales of £5.16bn, up from £4.73bn a year earlier, and earnings per share of 32.3p, up from 30.5p."Investor interest is likely to centre on the Primark retail chain where visibility regarding the outlook is cloudy and sentiment negative both in the context of a difficult environment for UK discretionary spending and given the difficult backdrop for input costs which are likely to have risen," writes the broker's head of investment research, Jeremy Batstone-Carr. "We have been wary regarding prospects for this business (c.27% total group sales, 35% group operating profit) for some time and suspect that margins are unlikely to revive in the near future. What AB Foods has to say regarding prospects for this business is likely to determine sentiment towards the shares in the immediate aftermath of the results' release," the broker reckons.Batstone-Carr thinks Primark's reported sales will be up by around 10% year on year, with like for like sales growth running at about 3%."With regard to the outlook we expect AB Foods to remain cautious but to continue to guide for higher earnings over the fiscal year. The extent of that profit growth is likely to be fairly subdued in our view, a reflection of rising cost pressures. We expect to have to lower estimates again in the wake of these results," Charles Stanley said.First quarter sales from pharmaceuticals leviathan GlaxoSmithKline (GSK) this time round will not benefit from the swine flu scare that was gripping public attention in the first three months of 2010."We expect pharmaceutical division sales to be £5.35bn (Q1 2010: £6.126bn, a decline of 14%) and consumer healthcare sales of £1.31bn (growth of 7%). This will broadly lead to a top line decline of 10%, compounded by the fact that GSK generated £782m of H1N1 pandemic vaccine and Relenza sales in Q1 2010, which will not be repeated," says Navid Malik of Matrix Group."The pipeline story for GSK remains key. The company has already flagged updates of 15 phase III assets before the end of 2012, we expect GSK to provide further updates on its pipeline," the broker added.House broker BarCap also notes Glaxo is going up against a tough comparative period "with £1.1bn pandemic, Avandia and Valtrex sales in 1Q10 [first quarter 2010]". It forecasts underlying sales growth in constant currencies of about 5%, in line with the full year 2010 performance."By 3Q11 we expect much cleaner comparisons with underlying sales moving close to reported sales growth. These issues may [have an] impact [on] quarterly margins with the chief executive officer at full year 2010 results saying that quarter to quarter margins are going to be a bit all over the place," BarCap added.The broker thinks an improved first quarter dividend of 16p may be in the offing, up from 15p last year. On the economic front, the major event is the meeting of the Federal Open Market Committee (FOMC), the US central bank's interest rate setting committee."We expect the FOMC to leave its asset purchase programme unchanged yet send a signal that the programme will end in June. We expect the reinvestment policy to be left in place and the chairman, during his press conference, to give guidance on the status of this policy after the purchase programme ends," Barclays Capital said.Of more parochial interest will be the preliminary estimate of UK gross domestic product in the first quarter. The consensus view is that we will see a 0.5% quarter on quarter increase. INTERIMSAssociated British Foods, FennerQUARTERLY EX-DIVIDEND DATEEquity Partnership Inv Co Income SharesINTERNATIONAL ECONOMIC ANNOUNCEMENTSRetail Sales (JPN)Small Business Confidence (JPN)GfK Consumer Confidence (GER) (07:00)Consumer Confidence Indicator (FRA) (07:45)Consumer Prices Index Industrial (GER) New Orders (EU) (10:00)MBA Mortgage Applications (US) (12:00)Durable Goods Orders (US) (13:30)Crude Oil Inventories (US) (15:30)FOMC Interest Rate (US) (17:15)GMSChina Wonder Ltd.FINALSGame Group, PraesepeIMSSAggreko, Barclays, GlobeOp Financial Services SA (DI), Premier FoodsAGMS4imprint Group, Aggreko, Athelney Trust, Barclays, Bodycote, DP Poland, Edinburgh UK Tracker Trust, JPMorgan US Smaller Companies Inv Trust, Premier Energy & Water Trust, Stanley Gibbons GroupTRADING ANNOUNCEMENTSCarpetrightUK ECONOMIC ANNOUNCEMENTSBBA Mortgage Lending Figures (09:30)GDP (Preliminary) (09:30)Index of Services (09:30)FINAL DIVIDEND PAYMENT DATELSL Property ServicesFINAL EX-DIVIDEND DATEAfrican Barrick Gold , ARM Holdings, Autoclenz Holdings, Centrica, Croda International, Dragon Oil, Drax Group, Edinburgh US Tracker Trust, Ferrexpo, Fresnillo, H.R. Owen, Henry Boot, Hydro International, IS Solutions, Lupus Capital, Playtech Ltd., Rathbone Brothers, Smith & Nephew, Tesco, Total ProduceQ1ARM Holdings, BP, GlaxoSmithKline, Wolfson Microelectronics---jh
More News
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
4 Apr 2024 13:08

UK dividends calendar - next 7 days

Friday 5 April 
BBGI Global Infrastructure SAdividend payment date
Molten Ventures PLCdividend payment date
Pennon Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Regional REIT Ltddividend payment date
Rights & Issues Investment Trust PLCdividend payment date
Sylvania Platinum Ltddividend payment date
Titon Holdings PLCdividend payment date
Triple Point Energy Transition PLCdividend payment date
Monday 8 April 
Alumasc Group PLCdividend payment date
LondonMetric Property PLCdividend payment date
Redrow PLCdividend payment date
Tuesday 9 April 
CT Global Managed Portfolio Trust PLCdividend payment date
Downing Strategic Micro-Cap Investment Trust PLCdividend payment date
Dunelm Group PLCspecial dividend payment date
Hays PLCdividend payment date
Renishaw PLCdividend payment date
Safestore Holdings PLCdividend payment date
Wednesday 10 April 
Assura PLCdividend payment date
Primorus Investments PLCspecial dividend payment date
Wilmington PLCdividend payment date
Thursday 11 April 
Amedeo Air Four Plus Ltdex-dividend payment date
Athelney Trust PLCdividend payment date
Aviva PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
Barratt Developments PLCex-dividend payment date
Begbies Traynor Group PLCex-dividend payment date
Bioventix PLCex-dividend payment date
Blackfinch Spring VCT PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caledonia Mining Corpex-dividend payment date
Capital & Regional PLCex-dividend payment date
Chesnara PLCex-dividend payment date
Colefax Group PLCdividend payment date
CT Private Equity Trust PLCex-dividend payment date
Downing Strategic Micro-Cap Investements Trust PLCex-dividend payment date
Driver Group PLCdividend payment date
F&C Investment Trust PLCex-dividend payment date
Foxtons Group PLCex-dividend payment date
Grafton Group PLCex-dividend payment date
GSK PLCdividend payment date
Harbour Energy PLCex-dividend payment date
Hargreaves Services PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
Hunting PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
International Personal Finance PLCex-dividend payment date
International Public Partnerships Ltdex-dividend payment date
ITV PLCex-dividend payment date
Johnson Service Group PLCex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Just Group PLCex-dividend payment date
Kenmare Resources PLCex-dividend payment date
Kerry Group PLCex-dividend payment date
Kings Arms Yard VCT PLCex-dividend payment date
Law Debenture Corp PLCdividend payment date
Lloyds Banking Group PLCex-dividend payment date
Lowland Investment Cos PLCex-dividend payment date
Luceco PLCex-dividend payment date
Man Group PLCex-dividend payment date
Manchester & London Investement Trust PLCex-dividend payment date
Marble Point Loan Financing Ltdex-dividend payment date
Mercantile Investment Trust PLCex-dividend payment date
Mobius Investment Trust PLCex-dividend payment date
MTI Wireless Edge Ltddividend payment date
North American Income Trust PLCex-dividend payment date
Northamber PLCex-dividend payment date
Octopus Apollo VCT PLCex-dividend payment date
Phoenix Group Holdings PLCex-dividend payment date
Reckitt Benckiser Group PLCex-dividend payment date
Ricardo PLCdividend payment date
Savills PLCex-dividend payment date
Schroder Asian Total Return Investment Cos PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Scottish American Investment Cos PLCdividend payment date
Smurfit Kappa Group PLCex-dividend payment date
Softcat PLCex-dividend payment date
Somero Enterprises Incex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Synectics PLCex-dividend payment date
TP ICAP Group PLCex-dividend payment date
Trifast PLCdividend payment date
TT Electronics PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.